Regeneron Pharmaceuticals Market Cap

Regeneron Pharmaceuticals has a market cap or net worth of €45.66 billion as of May 30, 2025. Its market cap has decreased by -53.51% in one year.

Market Cap

45.66B

Enterprise Value

32.51B

Revenue

13.03B

Ranking

n/a

PE Ratio

10.97

Stock Price

€437.00

Market Cap Chart

Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 131.41M to 45.66B, an increase of 34,643.22%. That is a compound annual growth rate of 19.47%.

Market Cap History

Date	Market Cap	% Change
May 30, 2025	45.66B	-38.32%
Dec 31, 2024	74.03B	-12.40%
Dec 29, 2023	84.50B	17.20%
Dec 30, 2022	72.10B	24.19%
Dec 31, 2021	58.06B	39.28%
Dec 31, 2020	41.68B	13.96%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SAP SE	306.17B
Siemens Aktiengesellschaft	165.91B
Deutsche Telekom AG	161.32B
Allianz SE	133.46B
Rheinmetall AG	85.50B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	73.55B
Siemens Energy AG	66.95B
Siemens Healthineers AG	52.52B

Market Cap Rankings